IP Library › Granted Patent US 7,001,611
Granted Patent B2
US 7,001,611 · App. 10/030,715 · Granted Feb 21, 2006

Compositions normalizing circadian rhythm

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,001,611
App. No.
10/030,715
Granted
Feb 21, 2006
Kind
B2
Abstract

The present invention provides a circadian rhythm normalizing composition containing astaxanthin and/or its ester as an active ingredient, and a composition having the action of enhancing the circadian rhythm normalizing action of melatonin by protecting melatonin. The composition can be in the form of a drug, a functional food, a food or a beverage. This composition has a circadian rhythm normalizing action, and has the action of preventing or alleviating sleep disorder and various diseases due to disturbance of the circadian rhythm.

Claims (3)

1. A method of normalizing circadian rhythm by administering to a patient suffering from disturbance of circadian rhythm, an effective amount of astaxanthin and/or an ester thereof, and an effective amount of melatonin.

2. The method of claim 1 wherein said effective amount of astaxanthin and/or an ester thereof ranges from 0.5–500 mg/day.

3. The method of claim 1 wherein said effective amount of astaxanthin and/or an ester thereof ranges from 5–50 mg/day.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2009
From: SUNTORY LTD.
To: SUNTORY HOLDINGS LTD.
Reel/Frame 022610/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2002
From: KISO, YOSHINOBU; ONO, YOSHIKO; NAGAI, KATSUYA
To: SUNTORY LIMITED
Reel/Frame 012809/0551 →